Jade Biosciences (JBIO) Times Interest Earned (2021 - 2024)
Jade Biosciences posted quarterly Times Interest Earned of -$98.33 for Q2 2024, up 99.52% year-on-year from -$49.29 in Q3 2023, and up 98.8% on a QoQ basis from -$8206.0 in Q1 2024.
Jade Biosciences (JBIO) has 4 years of Times Interest Earned data on file, last reported at -$98.33 in Q2 2024.
- For the quarter ending Q2 2024, Times Interest Earned rose 99.52% year-over-year to -$98.33; the trailing twelve-month figure through Mar 2025 stood at -$8134.2 (down 42.64% YoY), and the FY2023 full-year result was -$15831.0, down 11449.07% from the prior year.
- Times Interest Earned for Q2 2024 stood at -$98.33, up from -$8206.0 in the prior quarter.
- Across five years, Times Interest Earned topped out at $8268.0 in Q4 2021 and bottomed at -$20336.0 in Q2 2023.
- The 4-year median for Times Interest Earned is -$2407.9 (2022), against an average of -$5594.0.
- The widest annual swing landed in 2023, when Times Interest Earned tumbled 898.9%; it then jumped 99.52% in 2024.
- A 4-year view of Times Interest Earned shows it stood at $8268.0 in 2021, then plunged by 124.62% to -$2035.8 in 2022, then sank by 898.9% to -$20336.0 in 2023, then surged by 99.52% to -$98.33 in 2024.
- The last three Times Interest Earned figures came in at -$98.33 (Q2 2024), -$8206.0 (Q1 2024), and -$20336.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -98.33 |
| Mar 31, 2024 | -8,206.00 |
| Jun 30, 2023 | -20,336.00 |
| Mar 31, 2023 | -17,639.00 |
| Jun 30, 2022 | -2,035.83 |
| Dec 31, 2021 | 8,268.00 |
| Jun 30, 2021 | -1,924.67 |
| Mar 31, 2021 | -2,780.00 |